SCHEMBL6539753

SCHEMBL6539753

CCOC(=O)c1nc(-c2ccc(OC)nc2)c(-c2ccc(OCc3ccccc3)cc2)o1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
PABPC1 P11940 1/20 0.48
PPARD Q03181 2/20 0.48
MAOB P27338 1/20 0.43
HSP90AA1 P07900 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
PPARG P37231 1/20 0.41
MAPT P10636 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
PRMT5 O14744 2/20 0.41
TAAR1 Q96RJ0 1/20 0.41
LMNA P02545 1/20 0.41
ACACB O00763 1/20 0.41
ACACA Q13085 1/20 0.41
NPC1 O15118 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539702 0.89 PPARD (0.49) MEN1KMT2APPARDMAOBHSP90AA1
SCHEMBL6539225 0.89 PPARD (0.49) MEN1KMT2APPARDMAOBHSP90AA1
SCHEMBL6208143 0.89 MEN1 (0.53) MEN1KMT2APABPC1PPARDACACB
SCHEMBL6539675 0.88 MEN1 (0.51) MEN1KMT2APABPC1PPARDKDM4E
SCHEMBL6539033 0.86 MEN1 (0.48) MEN1KMT2APABPC1PPARDKDM4E
SCHEMBL6232912 0.84 MEN1 (0.48) MEN1KMT2APABPC1PPARDKDM4E
SCHEMBL6207251 0.84 MEN1 (0.48) MEN1KMT2APABPC1PPARDMAOB
SCHEMBL6540554 0.82 PPARD (0.53) MEN1KMT2APABPC1PPARDKDM4E
SCHEMBL6207437 0.82 KMT2A (0.46) MEN1KMT2APABPC1PPARDALDH1A1
SCHEMBL5787337 0.81 CYP19A1 (0.48) MEN1KMT2APPARDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 MEN1 4420/4885KMT2A 3081/4885PABPC1 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.